HealthVCF
Zebra Medical Vision Ltd. • Radiology • 05/12/2020
Device Purpose
HealthVCF is an AI-driven software that analyzes chest and abdominal CT scans to detect suspected vertebral compression fractures, aiming to improve patient care in bone health settings through prioritized case review. Its methodology relies on an artificial intelligence algorithm to flag relevant scans on a dedicated worklist application, operating passively and in parallel with standard clinical workflows to facilitate timely intervention without providing direct diagnostic information.
Summary
HealthVCF, from Zebra Medical Vision Ltd., is a software tool designed for clinicians in bone health settings to prioritize patients with suspected vertebral compression fractures (VCFs). It utilizes an artificial intelligence algorithm to analyze existing chest and abdominal CT scans, identifying and flagging studies suggestive of at least one VCF at the exam level. These flags are presented passively within a dedicated Zebra Worklist application, accessible via the Picture Archiving and Communication System (PACS), to assist clinicians in viewing potentially critical scans earlier. The system operates in a parallel workflow, without sending proactive alerts, altering the primary radiology worklist, or replacing the need for full patient evaluation and definitive diagnosis by a clinician; its function is strictly for triage and prioritization to aid in bone-health management. The software's architecture comprises modules for data input and validation (ensuring compatibility of age, modality, view), the core HealthVCF AI algorithm for fracture detection, an IMA integration feature to transmit results to the Zebra Worklist, and an error coding system for processing failures. Its performance was validated using a retrospective cohort of 611 anonymized chest and abdominal CT scans, which included 306 cases positive for moderate or severe VCFs and 305 negative cases. The HealthVCF algorithm demonstrated an area under the curve (AUC) of 0.9504, with a sensitivity of 90.20% and a specificity of 86.89% at its determined operating point. The average processing time for the device to analyze a study and provide notification was 61.36 seconds.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. What specific features or severities of vertebral compression fractures does the HealthVCF algorithm prioritize, and how does it differentiate between acute and chronic fractures based on CT analysis?; How does the performance of HealthVCF (sensitivity, specificity, AUC) vary across different CT scanner models, imaging protocols, contrast administration, or diverse patient demographics (e.g., age, bone density, co-morbidities)?; What is the quantifiable impact of HealthVCF on patient management timeliness, such as time-to-further-evaluation, and on clinical outcomes within Bone Health and Fracture Liaison Service programs?; How does the 'passive notification' system of HealthVCF integrate with various existing PACS worklist functionalities, and what are the human factors considerations for ensuring clinicians effectively notice and utilize these flags without contributing to alert fatigue or workflow disruption?; What is the learning curve for clinicians using the Zebra Worklist application, and what specific training or interface design elements ensure the three sagittal preview images are strictly used for informational purposes and not misinterpreted for diagnostic use, especially given their presence?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, SaaSBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly